Evidence map›Paper›PMID 31108373›Full record

ReviewCurrent opinion in neurobiology2019

The epitranscriptome and synaptic plasticity.

Mathieu N Flamand, Kate D Meyer

Abstract readReview
In one paragraph

Review in Current opinion in neurobiology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

31 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
  4. Review
  5. Single-cell mNature neuroscience · 2024
    Article
  6. Article
  7. Studying mFrontiers in molecular neuroscience · 2024
    Article
  8. Review
  9. Review
  10. Article
  11. Ghost authors revealed: The structure and function of human NWiley interdisciplinary reviews. RNA · 2023
    Review
  12. Review
  13. Review
  14. Article
  15. Article
  16. Psychosis spectrum illnesses as disorders of prefrontal critical period plasticity.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2023
    Review
  17. The dendritic engram.Frontiers in behavioral neuroscience · 2023
    Article
  18. Review
  19. RBM45 is an mCell reports · 2022
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Mathieu N FlamandDepartment of Biochemistry, Duke University School of Medicine, Durham, NC 27710, United States.
Kate D MeyerDepartment of Biochemistry, Duke University School of Medicine, Durham, NC 27710, United States. Electronic address: kate.meyer@duke.edu.

Funding

mRNA Methylation: a Novel Regulatory Mechanism in the Neuronal TranscriptomeR00MH104712 · NIMH · DUKE UNIVERSITY · PI MEYER, KATHRYN D · 2016 to 2018
$747k
CIHRNIMH NIH HHS R00 MH104712
6 · The paper itself

Abstract

RNA modifications, collectively referred to as 'the epitranscriptome,' have recently emerged as a pervasive feature of cellular mRNAs which have diverse impacts on gene expression. In the last several years, technological advances improving our ability to identify mRNA modifications, coupled with the discovery of proteins that add and remove these marks, have substantially expanded our knowledge of how the epitranscriptome shapes gene expression. Efforts to uncover functional roles for mRNA modifications have begun to reveal important roles for some marks within the nervous system, and animal models have emerged which demonstrate severe neurodevelopmental and neurocognitive abnormalities resulting from the loss of mRNA modification machinery. Here, we review the recent advances in the field of neuroepitranscriptomics, with a particular emphasis on how modifications to mRNAs within the brain contribute to synaptic activity.

Indexed as

BrainNeuronal PlasticityAnimalsRNA, MessengerRNA, Messenger

Identifiers

PMID31108373
PMCPMC6858947

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.